CDSCO consults on licensing devices manufactured in India
This article was originally published in RAJ Devices
Executive Summary
The Indian drug and medical device regulatory agency, the Central Drugs Standard Control Organization, has issued draft guidance explaining licensing requirements for devices manufactured within the country1. Stakeholders have 20 days to submit feedback on the proposed guideline, which was posted on the agency's website on 12 August.